Results 41 to 50 of about 7,815 (117)

The Quest to Reduce the Use of Gadolinium-based Contrast Agents: AI May Provide a Solution. [PDF]

Radiology, 2023
Bahl M.
europepmc   +1 more source

Cutaneous manifestations in patients with end-stage renal disease on hemodialysis. [PDF]

Caspian J Intern Med, 2023
Shirzadian Kebria A, Aryanian Z, Choobdar A, Akbari R.   +3 more
europepmc   +1 more source

Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases

, 2010
The aim of this article is to review the published cases of nephrogenic systemic fibrosis (NSF) in Japan. The Japanese medical literature database and MedLine were searched using the keywords NSF and nephrogenic fibrosing dermopathy (January 2000 to ...
Thomsen, H S, Y Tsushima, Tsushima, Y, Kanal, E, H S Thomsen, E Kanal   +5 more
core   +1 more source

Penile Calciphylaxis - A Rare, Yet Medically Treatable Disease. [PDF]

Indian J Nephrol, 2023
Sampathkumar SSK, Veerappan I, Raman RS, Chakravarthy T, Siddharth VA.   +4 more
europepmc   +1 more source

Unusual bleeds, unusual clots

, 2007
SummaryNine unusual bleeding and clotting disorders (or mimickers of such) are described in the format of case presentations, with focus on clinical history, images and diagnostic tests, followed by a discussion of the disease itself and a summarizing ...
S. Moll
core   +1 more source

Nephrogenic Systemic Fibrosis as a Complication after Gadolinium-Containing Contrast Agents: A Rapid Review. [PDF]

Int J Environ Res Public Health, 2021
Lange S, Mędrzycka-Dąbrowska W, Zorena K, Dąbrowski S, Ślęzak D, Malecka-Dubiela A, Rutkowski P.   +6 more
europepmc   +1 more source

Pediatric nephrogenic systemic fibrosis is rarely reported: A RADAR report

, 2014
Background: Nephrogenic systemic fibrosis is a fibrosing disorder associated with exposure to gadolinium-based contrast agents in people with severely compromised renal function.
West D.P., Nardone B., Belknap S.M., Haryani A., Dharnidharka V.R., Edwards B.J., Abu-Alfa A.K., Laumann A.E., Miller F.H., Godinez-Puig V., Raisch D.W., Saddleton E., Bull C., McKoy J.M., Cowper S.E.   +14 more
core   +1 more source

Clinical and Histopathological Features of Scleroderma-like Disorders: An Update. [PDF]

Medicina (Kaunas), 2021
Foti R, De Pasquale R, Dal Bosco Y, Visalli E, Amato G, Gangemi P, Foti R, Ramondetta A.   +7 more
europepmc   +1 more source

Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use. [PDF]

Tex Heart Inst J, 2022
Cheong BYC, Wilson JM, Preventza OA, Muthupillai R.   +3 more
europepmc   +1 more source

Nephrogenic systemic fibrosis: A frivolous entity. [PDF]

World J Nephrol, 2021
Bhargava V, Singh K, Meena P, Sanyal R.
europepmc   +1 more source